Jul 04, 2018

Inotersen Treatment for Patients With Hereditary Transthyretin Amyloidosis

Read more

Tegsedi™ to be Available on the NHS for hATTR Amyloidosis

Read more

ESC: Tafamidis Cuts Deaths, Admissions in TTR Cardiac Amyloidosis

Read more

FDA OKs Inotersen (Tegsedi) for Hereditary ATTR With Polyneuropathy

Read more

Inotersen: An Exciting Prospect for hATTR Amyloidosis Treatment

Read more

Subscribe to